Skeletal myoblast for cell therapy

Coronary Artery Disease

Volumn 16, Issue 2, 2005, Pages 105-110

  Menasché, Philippe ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Heart failure; Myocardial infarction; Skeletal myoblasts; Stem cells; Transplantation

Indexed keywords

CARDIAC MYOSIN; CHEMOKINE RECEPTOR CXCR4; CONNEXIN 43; FLUORODEOXYGLUCOSE F 18; GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSPLANTATION; CELL VIABILITY; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PROARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; MYOBLAST; NONHUMAN; PARACRINE SIGNALING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; REVIEW; SAFETY; SATELLITE CELL; TREATMENT INDICATION; TREATMENT OUTCOME;

ANIMALS; CELL TRANSPLANTATION; HEART DISEASES; HUMANS; MUSCLE, SKELETAL; MYOBLASTS; TISSUE ENGINEERING;

EID: 15344344077     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200503000-00005     Document Type: Review

References (33)

1. Menasche P, Hagege AA, Scorsin M, Pouzet B, Desnos M, Duboc D, et al. Myoblast transplantation for heart failure. Lancet 2001; 357:279-280.
2. Dowell JD, Rubart M, Pasumarthi KBS, Soonpaa MH, Field L. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 2003; 58:333-347.
3. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S, et al. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 2003; 100:7808-7811.
4. Reinecke H, Minami E, Poppa V, Murry C. Evidence for fusion between cardiac and skeletal muscle cells. Circulation 2004; 94:1-5.
5. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004; 94:678-685. A comprehensive demonstration of the paracrine effects of bone marrow cells related to their ability to secrete various angiogenic growth factors.
6. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114:763-776. An extensive description of a resident population of cardiac stem cells, which might be therapeutically exploited for myocardial regeneration.
7. Fujii T, Yau T, Weisel R, Ohno N, Mickle D, Shiono N, et al. Cell transplantation to prevent heart failure: a comparison of cell types. Ann Thorac Surg 2003; 76:2062-2070.
8. Murtuza B, Suzuki K, Bou-Gharios G, Beauchamp JR, Smolenski RT, Partridge TA, et al. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci USA 2004; 101:4216-4221.
9. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, et al. Autologous skeletal myoblast transplantation for severe post-infarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41:1078-1083. The report of the results of the first human study of autologous skeletal myoblast transplantation in heart failure patients.
10. Herreros J, Prosper F, Perez A, Avira JJ, Garcia-Velloso MJ, Barba J, et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003; 24:2012-2020.
11. Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rozwadowska N, Rzezniczak J, et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 2004; 148:531-537.
12. Dib N, McCarthy P, Dinsmore J, Pagani FD, Wright S, McLellan WR, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: interim analysis from the United States experience. Circulation 2002; 106(suppl II):II-463 (Abstract).
13. Smits PC, Geuns RJM, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure. J Am Coll Cardiol 2003; 42:2063-2069.
14. Brasselet C, Carrion C, Morichetti M, Messas E, Bruneval P, Vilquin JT, et al. Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium. J Am Coll Cardiol 2003; 41(suppl A):15.
15. Hagege AA, Carrion C, Menasche P, Vilquin JT, Duboc D, Marolleau JP, et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003; 361:491-492. The first demonstration, based on autopsy findings, of skeletal myoblast engraftment into a human infarcted heart.
16. Pagani F, DerSimonian R, Zawadska A, Wetzel K, Edge AS, Jacoby DB, et al. Autologous skeletal myoblasts transplanted to ischemia damaged myocardium in humans. J Am Coll Cardiol 2003; 41:879-888.
17. Makkar RR, Lill M, Chen PS. Stem cell therapy for myocardial repair: is it arrhythmogenic? J Am Coll Cardiol 2003; 42:2070-2072.
18. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001; 33:907-921.
19. Tambara K, Sakakibara Y, Sakaguchi G, Lu F, Permaratne GU, Lin X, et al. Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 2003; 108(suppl 1):II259-II263.
20. Reinecke H, Murry CE. Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? Cardiovasc Pathol 2000; 9:337-344.
21. Suzuki K, Murtuza B, Beauchamp JR, Smolenski RT, Varela-Carver A, Fukushima S, et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 2004, May 20 [Epub ahead of print].
22. Ott HC, Bonaros N, Marksteiner R, Wolf D, Margreiter E, Schachner T, et al. Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Eur J Cardiothorac Surg 2004; 25: 627-634.
23. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362:697-703. A carefully designed and executed study which documents homing of circulating bone marrow-derived cells into foci of infarction through SDF-1-CXCR4 interactions.
24. Germani A, Di Carlo A, Mangoni A, Straino S, Giacinti C, Turrini P, et al. Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol 2003; 163:1417-1428.
25. Koh GY, Soonpaa MH, Klug MG, Pride HP, Cooper BJ, Zipes DP, et al. Stable fetal cardiomyocyte graft in the hearts of dystrophic mice and dogs. J Clin Invest 1995; 96:2034-2042.
26. Yoo KJ, Li RK, Weisel RD, Mickle DA, Jia ZQ, Kim EJ, et al. Heart cell transplantation improves heart function in dilated cardiomyopathic hamsters. Circulation 2000; 102:III204-III209.
27. Thomson RB, Emani SM, Davis BH, Van Den Bos EJ, Morimoto Y, Craig D, et al. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Circulation 2003; 108(suppl I): I264-I271.
28. Agbulut O, Vandervelde S, Al Attar N, Larghero J, Ghostine S, Leobon B, et al. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 2004; 44:doi:10.1016.
29. Balsam LB, Wagers AJ, Christnsen JL, Kofidis T, Weissman IL, Robbins RC. Hematopoietic stem cells adopt mature hematopoietic fates in ischaemic myocardium. Nature 2004; 428:668-673.
30. Murry CE, Soonpa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428:664-668. An outstanding paper, which challenges the previous assumption that bone marrow hematopoietic cells can transdifferentiate into cardiomyocytes and analyses the methodologic reasons which may have lead to these earlier misinterpretations.
31. Planat-Benard V, Menard C, André M, Puceat M, Perez A, Gacia-Verdugo JM, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 2004; 94:223-229.
32. Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Terzic A, et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 2002; 16:1558-1566. A convincing demonstration that murine embryonic stem cells can engraft into rat infarcted myocardium, differentiate into cardiomyocytes and improve function without evidence for rejection or teratoma.
33. Min JY, Yang Y, Sullivan MF, Ke Q, Converso KL, Chen Y, et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 2003; 125:361-369.